Scientists identify an antiviral metabolite as a potential serum biomarker for SARS-CoV-2 infection

By | July 27, 2021
Scientists from the UK have recently identified an antiviral metabolite 3′-Deoxy-3′,4′-didehydro-cytidine as a potential serum biomarker to diagnose active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is currently available on the medRxiv* preprint server while awaiting peer review.